AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588307. A total of 59 filers reported holding AVEO PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.11 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $10,446,612 | +145.6% | 698,770 | +35.2% | 0.00% | – |
| Q3 2022 | $4,253,000 | +23.7% | 516,746 | -1.4% | 0.00% | – |
| Q2 2022 | $3,439,000 | +17.3% | 524,209 | -0.0% | 0.00% | – |
| Q1 2022 | $2,931,000 | +18.4% | 524,337 | -0.7% | 0.00% | – |
| Q4 2021 | $2,475,000 | -24.8% | 527,826 | -0.9% | 0.00% | – |
| Q3 2021 | $3,292,000 | +4.4% | 532,605 | +11.2% | 0.00% | – |
| Q2 2021 | $3,154,000 | -73.2% | 478,792 | -70.2% | 0.00% | – |
| Q1 2021 | $11,750,000 | +29.8% | 1,605,160 | +2.3% | 0.00% | – |
| Q4 2020 | $9,049,000 | -2.2% | 1,568,355 | +0.7% | 0.00% | – |
| Q3 2020 | $9,248,000 | +105.9% | 1,557,021 | +78.6% | 0.00% | – |
| Q2 2020 | $4,491,000 | +432.7% | 871,976 | +274.1% | 0.00% | – |
| Q1 2020 | $843,000 | – | 233,090 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 3,952,958 | $23,481,000 | 0.99% |
| Cormorant Asset Management, LP | 1,000,000 | $5,940,000 | 0.23% |
| WealthTrust Axiom LLC | 22,347 | $132,000 | 0.06% |
| SECTORAL ASSET MANAGEMENT INC | 100,000 | $594,000 | 0.05% |
| Virtu Financial LLC | 24,577 | $146,000 | 0.02% |
| PDT Partners, LLC | 61,839 | $367,000 | 0.02% |
| SABBY MANAGEMENT, LLC | 26,039 | $155,000 | 0.02% |
| MGO ONE SEVEN LLC | 10,000 | $59,000 | 0.01% |
| WINTON GROUP Ltd | 45,208 | $269,000 | 0.01% |
| Ancora Advisors LLC | 36,350 | $216,000 | 0.01% |